| Primary |
| Breast Cancer Metastatic |
16.9% |
| Immunosuppression |
16.0% |
| Renal Transplant |
8.8% |
| Product Used For Unknown Indication |
7.8% |
| Systemic Lupus Erythematosus |
6.6% |
| Immunosuppressant Drug Therapy |
4.8% |
| Multiple Sclerosis |
4.5% |
| Graft Versus Host Disease |
3.6% |
| Acute Lymphocytic Leukaemia |
3.4% |
| Rheumatoid Arthritis |
3.4% |
| Chronic Lymphocytic Leukaemia |
2.9% |
| Prophylaxis Against Renal Transplant Rejection |
2.9% |
| Prophylaxis Against Graft Versus Host Disease |
2.8% |
| Nephrotic Syndrome |
2.7% |
| Asthma |
2.6% |
| Prophylaxis |
2.4% |
| Bronchitis |
2.0% |
| Dermatomyositis |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Transplant Rejection |
1.9% |
|
| Neutropenia |
19.4% |
| Vomiting |
10.9% |
| Pyrexia |
5.3% |
| Drug Ineffective |
4.9% |
| Psychotic Disorder |
4.9% |
| Respiratory Failure |
4.9% |
| Weight Decreased |
4.9% |
| Pneumatosis Intestinalis |
4.5% |
| Headache |
4.0% |
| Renal Impairment |
4.0% |
| Sepsis |
4.0% |
| Thrombocytopenia |
4.0% |
| Ventricular Hypertrophy |
3.6% |
| White Blood Cell Count Increased |
3.6% |
| Drug-induced Liver Injury |
2.8% |
| Osteonecrosis |
2.8% |
| Pneumonia |
2.8% |
| Thyrotoxic Periodic Paralysis |
2.8% |
| Urticaria |
2.8% |
| Visual Impairment |
2.8% |
|
| Secondary |
| Product Used For Unknown Indication |
18.0% |
| Rheumatoid Arthritis |
10.2% |
| Immunosuppression |
9.3% |
| Drug Use For Unknown Indication |
8.5% |
| Renal Transplant |
7.6% |
| Prophylaxis Against Transplant Rejection |
7.2% |
| Premedication |
4.6% |
| Acute Lymphocytic Leukaemia |
4.5% |
| Prophylaxis |
4.0% |
| Liver Transplant |
3.5% |
| Lupus Nephritis |
2.8% |
| Systemic Lupus Erythematosus |
2.8% |
| Hypertension |
2.7% |
| B-cell Lymphoma |
2.6% |
| Infection Prophylaxis |
2.2% |
| Lymphoma |
2.0% |
| Prophylaxis Against Graft Versus Host Disease |
2.0% |
| Non-hodgkin's Lymphoma |
2.0% |
| Diffuse Large B-cell Lymphoma |
1.9% |
| Asthma |
1.7% |
|
| Transplant Rejection |
9.1% |
| Sepsis |
8.8% |
| Tendon Rupture |
7.9% |
| Thrombocytopenia |
6.9% |
| Vomiting |
6.8% |
| Pneumonia |
6.1% |
| Respiratory Failure |
5.2% |
| Renal Failure Acute |
5.1% |
| Neutropenia |
4.6% |
| Drug Ineffective |
4.1% |
| Malignant Neoplasm Progression |
4.1% |
| Tendonitis |
4.1% |
| Urinary Tract Infection |
4.1% |
| Systemic Lupus Erythematosus |
3.7% |
| Cytomegalovirus Infection |
3.5% |
| Renal Impairment |
3.5% |
| Pyrexia |
3.4% |
| Septic Shock |
3.3% |
| White Blood Cell Count Increased |
3.1% |
| Rotator Cuff Syndrome |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.8% |
| Drug Use For Unknown Indication |
15.2% |
| Rheumatoid Arthritis |
10.9% |
| Premedication |
6.8% |
| Prophylaxis |
5.0% |
| Multiple Sclerosis |
4.7% |
| Renal Transplant |
4.5% |
| Pain |
3.3% |
| Immunosuppression |
3.3% |
| Prophylaxis Against Graft Versus Host Disease |
3.0% |
| Hypertension |
2.7% |
| Prophylaxis Against Transplant Rejection |
2.7% |
| Infection Prophylaxis |
2.4% |
| Immunosuppressant Drug Therapy |
2.1% |
| Bone Marrow Conditioning Regimen |
1.8% |
| Asthma |
1.7% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Pneumonia |
1.3% |
| Liver Transplant |
1.1% |
| Acute Lymphocytic Leukaemia |
1.1% |
|
| Vomiting |
11.4% |
| Sepsis |
7.3% |
| Transplant Rejection |
6.8% |
| Pulmonary Embolism |
6.6% |
| Pyrexia |
6.1% |
| Pneumonia |
5.8% |
| Respiratory Failure |
5.7% |
| White Blood Cell Count Decreased |
5.6% |
| Thrombocytopenia |
5.5% |
| Weight Increased |
5.2% |
| Weight Decreased |
4.6% |
| Urinary Tract Infection |
4.2% |
| Drug Ineffective |
4.0% |
| Pain |
3.3% |
| Death |
3.1% |
| Thrombotic Microangiopathy |
3.1% |
| Renal Failure |
3.0% |
| Renal Failure Acute |
3.0% |
| Nausea |
2.9% |
| Myocardial Infarction |
2.8% |
|
| Interacting |
| Product Used For Unknown Indication |
46.1% |
| Diffuse Large B-cell Lymphoma |
7.8% |
| Anaesthesia |
5.2% |
| Cystic Fibrosis |
3.9% |
| Pain |
3.9% |
| Renal Transplant |
3.9% |
| Cardiac Disorder |
3.2% |
| Drug Use For Unknown Indication |
3.2% |
| Restless Legs Syndrome |
3.2% |
| Depression |
2.6% |
| Heart Transplant |
2.6% |
| Hypersensitivity |
1.9% |
| Infective Exacerbation Of Chronic Obstructive Airways Disease |
1.9% |
| Nephrotic Syndrome |
1.9% |
| Vasodilatation |
1.9% |
| Affective Disorder |
1.3% |
| Asthma |
1.3% |
| Bronchospasm |
1.3% |
| Candidiasis |
1.3% |
| Cardiac Failure |
1.3% |
|
| Drug Interaction |
14.8% |
| Hypertension |
7.4% |
| International Normalised Ratio Increased |
7.4% |
| Overdose |
7.4% |
| Vomiting |
7.4% |
| Cardio-respiratory Arrest |
3.7% |
| Depressed Level Of Consciousness |
3.7% |
| Disorientation |
3.7% |
| Dyspnoea |
3.7% |
| Fall |
3.7% |
| Fat Embolism |
3.7% |
| Flushing |
3.7% |
| Hot Flush |
3.7% |
| Hypokalaemia |
3.7% |
| Infectious Peritonitis |
3.7% |
| Liver Disorder |
3.7% |
| Peritonitis |
3.7% |
| Platelet Count Decreased |
3.7% |
| Suicidal Behaviour |
3.7% |
| Toxicity To Various Agents |
3.7% |
|
